Origimm Biotechnology

ProVaDis: Protection-based Vaccine Discovery

ORIGIMM PRESENTS AT THE RESI CONFERENCE, JANUARY 2015, SAN FRANCISCO

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides a networking platform for early stage life science companies to source investors, create relationships and raise funds.